The global antidiabetics market is witnessing substantial growth due to the increasing prevalence of diabetes, growing awareness regarding disease management, and continuous advancements in pharmaceutical therapies. Diabetes has emerged as one of the most significant public health challenges worldwide, creating a strong demand for effective treatment solutions that help manage blood glucose...

The Europe Medical Drug‑releasing Micropump market was valued at USD 0.35 billion in 2025 and is projected to grow from USD 0·38 billion in 2026 to USD 0·64 billion by 2034, exhibiting a CAGR of 9·3% during the forecast period. A Medical Drug‑releasing Micropump is a miniature infusion device designed for precise, controlled, and continuous drug delivery. These systems...

According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...

The metabolism drugs market is witnessing significant expansion as healthcare systems worldwide focus on addressing the growing burden of metabolic disorders. These medications play a crucial role in managing conditions associated with abnormal metabolic processes, including inherited metabolic diseases, enzyme deficiencies, and various chronic disorders that affect the body's ability to...

Detailed Analysis of Executive Summary Self-Monitoring of Blood Glucose (SMBG) Market Size and Share CAGR Value The global self-monitoring of blood glucose (SMBG) market size was valued at USD 21.70 billion in 2025 and is expected to reach USD 32.62 billion by 2033, at a CAGR of 5.23% during the forecast period The Self-Monitoring of Blood Glucose (SMBG) report makes available the...